R E Leake - JoVE Visualize

Showing results (41-50 of 45) with videos related to

Pageof 5

Sort By:

You have reached the last page of results.This site can display upto 45 results.

Steroids|July 1, 1994

Steroid-growth factor interaction in human prostate cancer. 1. Short-term effects of transforming growth factors on growth of human prostate cancer cellsG Carruba, R E Leake, F Rinaldi, et al.

Steroids|January 1, 1996

Steroid-growth factor interaction in human prostate cancer. 2. Effects of transforming growth factors on androgen metabolism of prostate cancer cellsG Carruba, O M Granata, R Farruggio, et al.

Journal of Clinical & Laboratory Immunology|June 1, 1990

Epidermal growth factor receptor, nuclear proliferation antigen and interleukin-2 receptor expression in prostatic cancerS N Lloyd, S McClinton, I L Brown, et al.

European Journal of Cancer (Oxford, England : 1990)|July 1, 1996

Immunoassays (ELISA) of urokinase-type plasminogen activator (uPA): report of an EORTC/BIOMED-1 workshopT J Benraad, J Geurts-Moespot, J Grøndahl-Hansen, et al.

British Journal of Cancer|March 31, 1999

Inhibition of transforming growth factor alpha (TGF-alpha)-mediated growth effects in ovarian cancer cell lines by a tyrosine kinase inhibitor ZM 252868B J Simpson, J M Bartlett, K G Macleod, et al.

Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:

Pageof 5

You have reached the last page of results.This site can display upto 45 results.

Steroids|July 1, 1994

Steroid-growth factor interaction in human prostate cancer. 1. Short-term effects of transforming growth factors on growth of human prostate cancer cellsG Carruba, R E Leake, F Rinaldi, et al.

Steroids|January 1, 1996

Steroid-growth factor interaction in human prostate cancer. 2. Effects of transforming growth factors on androgen metabolism of prostate cancer cellsG Carruba, O M Granata, R Farruggio, et al.

Journal of Clinical & Laboratory Immunology|June 1, 1990

Epidermal growth factor receptor, nuclear proliferation antigen and interleukin-2 receptor expression in prostatic cancerS N Lloyd, S McClinton, I L Brown, et al.

European Journal of Cancer (Oxford, England : 1990)|July 1, 1996

Immunoassays (ELISA) of urokinase-type plasminogen activator (uPA): report of an EORTC/BIOMED-1 workshopT J Benraad, J Geurts-Moespot, J Grøndahl-Hansen, et al.

British Journal of Cancer|March 31, 1999

Inhibition of transforming growth factor alpha (TGF-alpha)-mediated growth effects in ovarian cancer cell lines by a tyrosine kinase inhibitor ZM 252868B J Simpson, J M Bartlett, K G Macleod, et al.

Pageof 5